Medlive Technology Co., a leading player in the healthcare technology sector, is headquartered in China (CN) and operates extensively across Asia and beyond. Founded in 2015, the company has rapidly established itself as a pioneer in medical data solutions, telemedicine, and healthcare management systems. Medlive's core offerings include advanced medical imaging software and integrated health information platforms, designed to enhance clinical decision-making and improve patient outcomes. What sets Medlive apart is its commitment to innovation, leveraging cutting-edge technology to streamline healthcare processes. With a strong market position, Medlive Technology Co. has achieved significant milestones, including partnerships with major healthcare institutions and recognition for its contributions to digital health. The company continues to drive advancements in the industry, making healthcare more accessible and efficient for providers and patients alike.
How does Medlive Technology Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Medlive Technology Co's score of 28 is higher than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Medlive Technology Co., based in China (CN), reported total carbon emissions of approximately 753,783 kg CO2e. This total comprises 0 kg CO2e from Scope 1 emissions, 47,061 kg CO2e from Scope 2 emissions, and 706,722 kg CO2e from Scope 3 emissions. The previous year, 2023, saw total emissions of about 828,278 kg CO2e, with 0 kg CO2e from Scope 1, 60,102 kg CO2e from Scope 2, and 768,176 kg CO2e from Scope 3. Medlive has not set specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or commitments to frameworks such as the Science Based Targets initiative (SBTi). The company’s emissions data is not cascaded from a parent organization, indicating that it operates independently in its reporting and climate commitments. Overall, Medlive Technology Co. is focused on understanding and managing its carbon footprint, with a clear need for future commitments to enhance its sustainability efforts.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | - | - | - |
| Scope 2 | 67,396,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | 000,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Medlive Technology Co has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.